Viracept

In the US, Viracept (nelfinavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

• Viracept


• Viracept Powder

UK matches:

• Viracept Film-coated Tablets (Roche Products Limited) (SPC)

Ingredient matches for Viracept

Nelfinavir

Nelfinavir is reported as an ingredient of Viracept in the following countries:

• Ireland

Nelfinavir mesilate (a derivative of Nelfinavir) is reported as an ingredient of Viracept in the following countries:

• Argentina


• Belgium


• Bosnia & Herzegowina


• Botswana


• Brazil


• Cambodia


• Canada


• Chile


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Ecuador


• Egypt


• Estonia


• Ethiopia


• Finland


• France


• Georgia


• Germany


• Ghana


• Greece


• Hong Kong


• Hungary


• Iceland


• Israel


• Italy


• Japan


• Kazakhstan


• Kenya


• Laos


• Luxembourg


• Malawi


• Malaysia


• Mexico


• Morocco


• Namibia


• Netherlands


• Nigeria


• Oman


• Paraguay


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sudan


• Switzerland


• Taiwan


• Tanzania


• Thailand


• Uganda


• United Arab Emirates


• United Kingdom


• United States


• Uruguay


• Venezuela


• Zambia


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.